Nifty

:

22570.35

Sensex

:

74339.44

167.95 (0.75%)
486.50 (0.66%)

Login

Nifty
Sensex

:
:

22570.35
74339.44

167.95 (0.75%)
486.50 (0.66%)

Marksans Pharma Ltd.

Pharmaceuticals & Drugs - Global

Rating :

68/99

BSE: 524404 | NSE: MARKSANS

Watchlist

NSE BSE

168.15

24-Apr-2024

Open
High
Low
Previous Close

170.20
172.00
167.15
169.80

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1696056
2872.48
185.50
70.55

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

7,606.35
23.97
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

6,981.03
0.30%
3.88

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.39
13.12
10.41

EBITDA CAGR (%)

10 Years
5 Years
3 Years

11.53
20.76
-0.02

PAT CAGR (%)

10 Years
5 Years
3 Years

13.99
28.35
4.12

P:E (Median)

8 Years
5 Years
3 Years

15.44
11.87
13.94

P:BV (Average)

8 Years
5 Years
3 Years

2.75
2.35
2.57

EV:EBITDA (Average)

8 Years
5 Years
3 Years

12.65
7.89
8.51

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 241.36 172.75 39.72% 204.67 170.26 20.21% 182.04 159.15 14.38% 153.05 176.28 -13.18%
Expenses 199.39 148.93 33.88% 167.37 136.49 22.62% 155.28 147.55 5.24% 130.34 149.41 -12.76%
EBITDA 41.97 23.82 76.20% 37.30 33.77 10.45% 26.76 11.61 130.49% 22.71 26.87 -15.48%
EBIDTM 17.39% 13.79% 18.22% 19.84% 14.70% 7.29% 14.84% 15.24%
Other Income 1.32 15.71 -91.60% 15.93 21.03 -24.25% 32.62 19.43 67.88% 4.30 7.65 -43.79%
Interest 0.27 0.85 -68.24% 0.23 1.29 -82.17% 0.26 0.82 -68.29% 0.66 1.28 -48.44%
Depreciation 8.43 4.18 101.67% 8.50 4.53 87.64% 4.72 4.52 4.42% 3.51 4.61 -23.86%
PBT 34.60 34.50 0.29% 44.50 48.98 -9.15% 54.40 25.70 111.67% 22.84 28.63 -20.22%
Tax 9.31 8.88 4.84% 13.21 8.75 50.97% 10.20 6.50 56.92% 5.04 7.20 -30.00%
PAT 25.29 25.62 -1.29% 31.29 40.23 -22.22% 44.19 19.21 130.04% 17.81 21.43 -16.89%
PATM 10.48% 14.83% 15.29% 23.63% 24.28% 12.07% 11.64% 12.16%
EPS 0.56 0.57 -1.75% 0.69 0.89 -22.47% 0.98 0.42 133.33% 0.39 0.47 -17.02%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 586.13 479.83 22.15% 531.24 452.56 17.39% 500.03 433.77 15.28% 485.98 418.04 16.25%
Expenses 453.11 403.19 12.38% 417.29 372.30 12.08% 398.07 360.91 10.30% 376.43 354.40 6.22%
EBITDA 133.02 76.64 73.56% 113.95 80.27 41.96% 101.97 72.86 39.95% 109.55 63.64 72.14%
EBIDTM 22.70% 15.97% 21.45% 17.74% 20.39% 16.80% 22.54% 15.22%
Other Income 4.80 17.65 -72.80% 19.00 14.15 34.28% 10.10 16.50 -38.79% 11.01 15.34 -28.23%
Interest 3.16 2.35 34.47% 1.63 2.54 -35.83% 1.58 1.80 -12.22% 2.44 5.03 -51.49%
Depreciation 22.00 12.74 72.68% 17.55 14.05 24.91% 13.66 11.12 22.84% 13.94 21.36 -34.74%
PBT 112.66 79.20 42.25% 113.77 77.83 46.18% 96.83 76.45 26.66% 104.17 52.60 98.04%
Tax 29.69 16.90 75.68% 29.92 17.71 68.94% 26.39 16.26 62.30% 21.46 22.95 -6.49%
PAT 82.97 62.31 33.16% 83.85 60.12 39.47% 70.44 60.18 17.05% 82.71 29.65 178.95%
PATM 14.15% 12.98% 15.78% 13.28% 14.09% 13.87% 17.02% 7.09%
EPS 1.84 1.57 17.20% 1.84 1.52 21.05% 1.52 1.46 4.11% 1.81 0.69 162.32%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 781.12 655.20 658.29 599.55 433.42 424.16 294.66 215.84 358.13 405.59 314.94 Net Sales Growth 15.13% -0.47% 9.80% 38.33% 2.18% 43.95% 36.52% -39.73% -11.70% 28.78% Cost Of Goods Sold 451.41 394.44 377.59 337.91 245.41 236.34 169.35 112.37 178.18 218.16 169.63 Gross Profit 329.71 260.75 280.70 261.63 188.00 187.82 125.31 103.47 179.95 187.44 145.31 GP Margin 42.21% 39.80% 42.64% 43.64% 43.38% 44.28% 42.53% 47.94% 50.25% 46.21% 46.14% Total Expenditure 652.38 563.30 544.57 485.84 361.93 360.83 265.52 202.15 258.76 299.58 236.23 Power & Fuel Cost - 14.24 11.49 10.90 8.95 8.44 7.26 7.21 7.55 7.74 6.46 % Of Sales - 2.17% 1.75% 1.82% 2.06% 1.99% 2.46% 3.34% 2.11% 1.91% 2.05% Employee Cost - 56.09 60.46 54.64 48.51 46.33 45.86 39.77 26.13 23.65 21.39 % Of Sales - 8.56% 9.18% 9.11% 11.19% 10.92% 15.56% 18.43% 7.30% 5.83% 6.79% Manufacturing Exp. - 4.24 5.25 56.39 32.15 12.69 11.52 11.99 13.99 15.42 13.33 % Of Sales - 0.65% 0.80% 9.41% 7.42% 2.99% 3.91% 5.56% 3.91% 3.80% 4.23% General & Admin Exp. - 21.15 16.58 14.79 16.19 22.68 10.95 10.61 9.42 7.50 7.95 % Of Sales - 3.23% 2.52% 2.47% 3.74% 5.35% 3.72% 4.92% 2.63% 1.85% 2.52% Selling & Distn. Exp. - 53.97 59.37 8.56 10.37 34.30 20.58 20.20 23.48 21.52 17.46 % Of Sales - 8.24% 9.02% 1.43% 2.39% 8.09% 6.98% 9.36% 6.56% 5.31% 5.54% Miscellaneous Exp. - 19.15 13.84 2.64 0.34 0.04 0.00 0.00 0.00 5.59 17.46 % Of Sales - 2.92% 2.10% 0.44% 0.08% 0.01% 0% 0% 0% 1.38% 0% EBITDA 128.74 91.90 113.72 113.71 71.49 63.33 29.14 13.69 99.37 106.01 78.71 EBITDA Margin 16.48% 14.03% 17.28% 18.97% 16.49% 14.93% 9.89% 6.34% 27.75% 26.14% 24.99% Other Income 54.17 60.48 42.25 31.16 0.17 7.93 7.43 17.75 13.21 12.82 8.41 Interest 1.42 3.61 3.80 5.34 7.29 6.56 7.67 4.49 6.20 13.11 15.21 Depreciation 25.16 16.74 17.66 15.19 11.64 8.69 12.25 15.00 14.75 9.03 8.66 PBT 156.34 132.03 134.51 124.33 52.73 56.01 16.65 11.95 91.63 96.69 63.26 Tax 37.76 29.17 30.52 25.95 14.82 12.39 4.23 0.40 20.14 29.58 7.70 Tax Rate 24.15% 22.09% 22.69% 20.87% 28.11% 22.12% 25.41% 3.35% 21.98% 30.59% 12.17% PAT 118.58 102.87 103.99 98.38 37.90 43.62 12.43 11.55 71.49 67.11 55.56 PAT before Minority Interest 118.58 102.87 103.99 98.38 37.90 43.62 12.43 11.55 71.49 67.11 55.56 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 15.18% 15.70% 15.80% 16.41% 8.74% 10.28% 4.22% 5.35% 19.96% 16.55% 17.64% PAT Growth 11.35% -1.08% 5.70% 159.58% -13.11% 250.93% 7.62% -83.84% 6.53% 20.79% EPS 2.62 2.27 2.29 2.17 0.84 0.96 0.27 0.25 1.58 1.48 1.23

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 2,103.38 1,852.14 1,490.84 1,376.18 1,134.21 1,000.07 912.69 767.16 893.33 796.69 630.00 Net Sales Growth 17.89% 24.23% 8.33% 21.33% 13.41% 9.57% 18.97% -14.12% 12.13% 26.46% Cost Of Goods Sold 1,012.15 921.36 716.81 595.05 567.83 498.01 523.13 458.74 509.69 445.44 367.93 Gross Profit 1,091.23 930.78 774.02 781.13 566.38 502.07 389.57 308.42 383.63 351.25 262.07 GP Margin 51.88% 50.25% 51.92% 56.76% 49.94% 50.20% 42.68% 40.20% 42.94% 44.09% 41.60% Total Expenditure 1,644.90 1,512.82 1,231.96 1,036.58 941.96 867.92 834.31 734.24 760.91 620.86 516.04 Power & Fuel Cost - 24.50 18.59 16.42 14.38 14.34 11.83 13.27 12.58 9.72 7.80 % Of Sales - 1.32% 1.25% 1.19% 1.27% 1.43% 1.30% 1.73% 1.41% 1.22% 1.24% Employee Cost - 239.37 220.30 197.32 168.42 159.07 147.75 149.70 122.42 72.61 66.44 % Of Sales - 12.92% 14.78% 14.34% 14.85% 15.91% 16.19% 19.51% 13.70% 9.11% 10.55% Manufacturing Exp. - 18.73 12.73 127.47 113.32 77.14 59.90 47.34 50.44 37.59 30.11 % Of Sales - 1.01% 0.85% 9.26% 9.99% 7.71% 6.56% 6.17% 5.65% 4.72% 4.78% General & Admin Exp. - 52.58 37.74 50.67 45.52 51.03 42.51 37.52 36.01 15.35 16.13 % Of Sales - 2.84% 2.53% 3.68% 4.01% 5.10% 4.66% 4.89% 4.03% 1.93% 2.56% Selling & Distn. Exp. - 102.53 119.05 33.54 32.15 68.36 49.14 27.66 29.77 34.47 27.63 % Of Sales - 5.54% 7.99% 2.44% 2.83% 6.84% 5.38% 3.61% 3.33% 4.33% 4.39% Miscellaneous Exp. - 153.75 106.73 16.10 0.34 -0.01 0.05 0.00 0.00 5.67 27.63 % Of Sales - 8.30% 7.16% 1.17% 0.03% 0.00% 0.01% 0% 0% 0.71% 0% EBITDA 458.49 339.32 258.88 339.60 192.25 132.15 78.38 32.92 132.42 175.83 113.96 EBITDA Margin 21.80% 18.32% 17.36% 24.68% 16.95% 13.21% 8.59% 4.29% 14.82% 22.07% 18.09% Other Income 44.91 59.31 41.85 6.69 0.33 4.62 8.47 18.85 12.72 12.23 7.28 Interest 8.81 9.13 8.45 7.99 8.75 9.66 10.22 6.78 10.16 16.05 19.13 Depreciation 67.15 51.85 44.78 36.15 26.66 22.80 26.84 30.09 28.13 16.13 15.69 PBT 427.43 337.65 247.51 302.16 157.17 104.31 49.80 14.90 106.85 155.88 86.41 Tax 107.46 72.33 60.70 63.63 36.42 23.87 14.00 3.56 24.11 43.92 12.79 Tax Rate 25.14% 21.42% 24.52% 21.06% 23.17% 22.88% 28.11% 23.89% 22.56% 28.18% 14.80% PAT 319.97 266.31 184.56 235.94 117.02 76.46 32.94 8.83 78.51 109.39 71.90 PAT before Minority Interest 317.35 265.32 186.81 238.54 120.75 80.44 35.80 11.33 82.74 111.96 73.62 Minority Interest -2.62 0.99 -2.25 -2.60 -3.73 -3.98 -2.86 -2.50 -4.23 -2.57 -1.72 PAT Margin 15.21% 14.38% 12.38% 17.14% 10.32% 7.65% 3.61% 1.15% 8.79% 13.73% 11.41% PAT Growth 50.74% 44.29% -21.78% 101.62% 53.05% 132.12% 273.05% -88.75% -28.23% 52.14% EPS 7.06 5.88 4.07 5.21 2.58 1.69 0.73 0.19 1.73 2.41 1.59

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 1,111.32 784.67 599.72 505.63 470.57 428.97 418.88 422.70 358.18 159.92 Share Capital 45.32 40.93 40.93 40.93 40.93 40.93 40.93 53.43 53.43 52.03 Total Reserves 1,066.01 650.64 558.79 464.69 429.64 388.04 377.95 369.27 304.75 107.89 Non-Current Liabilities 26.48 14.41 23.93 24.79 18.39 17.09 17.30 0.31 0.50 21.68 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 19.82 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 12.66 1.86 2.11 1.47 1.36 1.08 0.96 0.00 0.00 0.00 Current Liabilities 240.91 190.39 137.26 79.73 133.39 111.22 109.59 111.19 168.43 194.83 Trade Payables 111.58 74.45 64.16 56.65 37.23 33.68 20.60 31.41 44.58 40.50 Other Current Liabilities 97.65 78.95 42.70 10.92 7.34 8.79 0.71 0.68 39.88 73.59 Short Term Borrowings 0.00 5.00 0.00 0.00 77.33 66.31 73.23 40.62 43.52 58.06 Short Term Provisions 31.68 31.99 30.40 12.15 11.50 2.45 15.04 38.49 40.45 22.68 Total Liabilities 1,378.71 989.47 760.91 610.15 622.35 557.28 545.77 534.20 527.11 376.43 Net Block 143.94 135.51 129.09 115.18 102.61 87.89 93.92 97.47 90.01 66.82 Gross Block 318.89 301.34 277.25 248.77 224.90 201.83 195.61 184.48 162.47 130.24 Accumulated Depreciation 174.95 165.83 148.16 133.59 122.28 113.94 101.69 87.01 72.45 63.42 Non Current Assets 440.58 375.75 369.32 355.73 339.98 324.78 329.16 330.16 158.45 135.93 Capital Work in Progress 3.90 0.00 0.00 0.00 0.00 0.00 0.36 0.00 0.00 0.00 Non Current Investment 265.75 236.07 236.07 236.07 236.07 236.07 234.29 231.44 67.62 67.62 Long Term Loans & Adv. 26.98 4.16 4.16 4.47 1.29 0.82 0.59 1.25 0.83 1.50 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 938.13 613.73 391.60 254.41 282.37 232.51 216.61 204.04 368.66 240.50 Current Investments 0.54 0.44 0.26 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 130.95 103.67 93.69 74.60 70.36 42.29 29.24 43.74 51.03 55.61 Sundry Debtors 305.49 246.78 168.93 161.87 177.83 168.87 154.80 133.41 124.63 112.38 Cash & Bank 440.26 224.05 105.61 3.35 1.80 0.71 2.56 3.13 167.54 33.37 Other Current Assets 60.88 12.06 1.91 0.82 32.38 20.62 30.01 23.76 25.46 39.14 Short Term Loans & Adv. 53.71 26.73 21.20 13.76 24.91 14.54 29.92 23.76 25.46 39.14 Net Current Assets 697.22 423.34 254.34 174.68 148.98 121.28 107.02 92.85 200.23 45.67 Total Assets 1,378.71 989.48 760.92 610.14 622.35 557.29 545.77 534.20 527.11 376.43

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 1,745.16 1,202.27 886.50 636.01 542.48 470.86 433.43 454.32 379.76 142.18 Share Capital 45.32 40.93 40.93 40.93 40.93 40.93 40.93 53.43 53.43 52.03 Total Reserves 1,699.85 1,068.24 845.56 595.08 501.55 429.93 392.50 400.89 326.33 90.15 Non-Current Liabilities 93.81 57.05 23.70 24.15 17.14 15.64 16.07 -1.91 1.46 22.16 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 19.82 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 12.74 1.86 2.11 1.47 1.36 1.08 0.96 0.00 0.00 0.00 Current Liabilities 365.36 380.08 298.97 228.75 232.62 234.68 296.06 259.43 286.24 319.12 Trade Payables 230.60 200.08 168.66 110.33 106.07 77.83 161.78 118.98 107.02 83.18 Other Current Liabilities 42.20 96.80 79.69 58.86 20.90 10.08 0.71 0.68 39.88 96.58 Short Term Borrowings 41.59 41.29 18.74 18.84 99.91 117.41 109.71 87.89 82.19 105.54 Short Term Provisions 50.97 41.92 31.88 40.72 5.74 29.36 23.85 51.88 57.15 33.82 Total Liabilities 2,224.24 1,660.10 1,228.03 902.02 802.46 730.73 751.81 720.20 675.56 490.10 Net Block 486.31 428.31 309.36 302.72 269.73 279.38 266.98 269.65 165.90 145.65 Gross Block 828.26 726.26 551.92 565.39 506.26 495.35 456.49 429.47 297.78 261.70 Accumulated Depreciation 341.95 297.96 242.56 262.67 236.54 215.97 189.52 159.82 131.89 116.05 Non Current Assets 524.57 435.04 325.20 308.45 271.02 280.19 267.92 280.06 166.72 147.15 Capital Work in Progress 9.87 2.57 11.68 0.00 0.00 0.00 0.36 0.00 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 28.40 4.16 4.16 5.73 1.29 0.82 0.59 10.41 0.83 1.50 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,699.67 1,225.07 902.82 593.59 531.44 450.54 483.88 440.15 508.83 342.95 Current Investments 0.54 0.44 0.26 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 484.74 424.44 404.32 241.84 293.25 218.12 190.09 167.79 130.11 102.59 Sundry Debtors 416.85 394.78 271.95 243.35 176.60 176.91 247.58 217.29 183.45 169.61 Cash & Bank 714.96 349.26 212.18 93.73 33.54 39.88 25.16 35.30 185.27 46.95 Other Current Assets 82.58 24.36 14.11 11.26 28.06 15.63 21.05 19.76 10.01 23.80 Short Term Loans & Adv. 59.84 31.79 0.00 3.40 0.00 0.00 20.96 19.76 10.01 23.80 Net Current Assets 1,334.31 844.98 603.85 364.83 298.82 215.86 187.82 180.71 222.60 23.83 Total Assets 2,224.24 1,660.11 1,228.02 902.04 802.46 730.73 751.80 720.21 675.55 490.10

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 51.73 55.97 106.92 107.58 19.81 15.63 -13.62 64.76 112.03 54.18 PBT 132.03 134.51 124.33 52.73 56.01 16.65 11.95 91.63 96.69 63.26 Adjustment 10.91 -7.93 -8.82 19.17 11.57 20.00 12.50 8.82 17.75 14.87 Changes in Working Capital -59.60 -38.77 11.62 46.17 -34.91 -16.33 -22.39 -15.35 28.53 -15.89 Cash after chg. in Working capital 83.34 87.80 127.13 118.06 32.67 20.32 2.06 85.09 142.97 62.24 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -31.62 -31.83 -20.21 -10.49 -12.86 -4.68 -15.69 -20.33 -30.94 -8.06 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -194.62 -128.06 8.87 -24.15 -20.20 -7.55 -7.69 -177.34 -29.14 -2.01 Net Fixed Assets -21.45 -24.09 -28.48 -23.87 -23.07 -5.86 -11.49 -22.01 -32.23 -2.62 Net Investments -29.78 -0.18 -0.26 0.00 0.00 -1.78 -2.85 -163.82 0.00 0.00 Others -143.39 -103.79 37.61 -0.28 2.87 0.09 6.65 8.49 3.09 0.61 Cash from Financing Activity 210.02 70.86 -13.53 -81.87 0.96 -9.98 20.74 -51.83 51.28 -19.21 Net Cash Inflow / Outflow 67.12 -1.23 102.26 1.55 0.56 -1.90 -0.57 -164.41 134.17 32.96 Opening Cash & Equivalents 81.19 82.42 3.35 1.80 0.55 2.45 3.13 167.54 33.37 0.41 Closing Cash & Equivalent 148.31 81.19 105.61 3.35 1.12 0.55 2.56 3.13 167.54 33.37

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 237.41 99.26 178.59 233.33 27.40 50.09 14.06 30.80 154.51 64.84 PBT 337.65 247.51 302.16 157.17 104.31 49.80 14.90 106.85 109.40 71.91 Adjustment 74.24 35.31 56.57 42.04 31.88 43.99 26.58 39.63 24.26 19.57 Changes in Working Capital -111.47 -110.70 -131.61 59.12 -81.79 -36.23 -6.04 -88.14 20.27 -26.01 Cash after chg. in Working capital 300.43 172.12 227.12 258.33 54.40 57.56 35.44 58.34 153.94 65.47 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -63.01 -72.86 -48.53 -25.00 -27.00 -7.46 -21.37 -27.54 -0.89 -0.27 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -259.21 -84.39 -44.85 -59.58 -13.48 -38.81 -20.73 -123.01 -33.19 -4.49 Net Fixed Assets -21.45 -24.09 -28.48 -23.87 -23.07 -5.86 -11.49 -22.01 -32.23 -2.62 Net Investments -29.78 -0.18 -0.26 0.00 0.00 -1.78 -2.85 -163.82 0.00 0.00 Others -207.98 -60.12 -16.11 -35.71 9.59 -31.17 -6.39 62.82 -0.96 -1.87 Cash from Financing Activity 197.83 79.51 -15.29 -113.55 -20.78 3.38 -3.47 -57.75 16.99 -29.28 Net Cash Inflow / Outflow 176.03 94.38 118.46 60.19 -6.86 14.67 -10.14 -149.96 138.32 31.07 Opening Cash & Equivalents 206.41 112.03 93.73 33.54 39.72 25.05 35.30 185.27 46.95 15.88 Closing Cash & Equivalent 382.44 206.41 212.18 93.73 32.85 39.72 25.16 35.30 185.27 46.95

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 24.52 16.90 14.65 12.35 11.50 10.48 10.23 10.02 8.45 3.80 ROA 8.69% 11.88% 14.35% 6.15% 7.40% 2.25% 2.14% 13.47% 14.85% 16.18% ROE 11.41% 16.11% 17.80% 7.77% 9.70% 2.93% 2.79% 18.91% 27.27% 45.75% ROCE 14.27% 19.91% 23.46% 11.39% 11.99% 4.92% 3.44% 22.45% 33.41% 34.89% Fixed Asset Turnover 2.24 2.30 2.30 1.83 1.99 1.48 1.14 2.06 2.77 2.44 Receivable days 144.90 114.03 99.91 143.04 149.17 200.47 243.69 131.50 106.64 118.09 Inventory Days 61.56 54.14 50.83 61.04 48.47 44.31 61.71 48.29 47.98 61.96 Payable days 86.07 66.99 65.25 47.33 37.28 36.94 45.72 53.08 52.33 53.91 Cash Conversion Cycle 120.38 101.18 85.49 156.75 160.37 207.84 259.68 126.70 102.30 126.15 Total Debt/Equity 0.00 0.01 0.00 0.00 0.17 0.16 0.17 0.10 0.14 0.56 Interest Cover 37.54 36.44 24.26 8.23 9.54 3.17 3.66 15.77 8.37 5.16

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 38.51 27.10 21.66 15.54 13.25 11.50 10.59 10.79 8.97 3.34 ROA 13.66% 12.94% 22.40% 14.17% 10.49% 4.83% 1.54% 11.86% 19.21% 16.52% ROE 18.59% 18.72% 31.33% 20.49% 15.88% 7.92% 2.59% 20.45% 45.15% 73.02% ROCE 22.89% 23.82% 39.76% 25.57% 18.51% 10.60% 3.99% 23.16% 44.64% 38.30% Fixed Asset Turnover 2.62 2.42 2.49 2.12 2.00 1.92 1.73 2.46 2.85 2.43 Receivable days 72.63 78.56 67.57 67.57 64.51 84.88 110.59 81.87 80.88 87.17 Inventory Days 81.36 97.65 84.73 86.10 93.32 81.63 85.14 60.86 53.30 52.22 Payable days 85.31 93.88 85.57 45.09 38.48 55.10 65.56 54.58 56.06 48.85 Cash Conversion Cycle 68.67 82.33 66.73 108.58 119.35 111.40 130.17 88.15 78.13 90.54 Total Debt/Equity 0.02 0.04 0.02 0.03 0.18 0.25 0.25 0.19 0.23 1.12 Interest Cover 37.99 30.31 38.84 18.97 11.80 5.87 3.20 11.52 10.72 5.52

Top Investors:

orbimed asia iv mauritius fvci limited

quant mutual fund - quant small cap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Marksans Pharma - Quarterly Results
13th Feb 2024, 14:51 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback